ursolic acid has been researched along with Hyperlipemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, HL; Tang, KX; Wang, YL; Wang, ZJ; Yin, M | 1 |
| Hanlin, S; Kexuan, T; Ming, Y; Yuliang, W; Zejian, W | 1 |
| Bernhard, D; Frotschnig, S; Huck, C; Laufer, G; Messner, B; Ploner, C; Ringer, T; Ritsch, A; Steinacher-Nigisch, A; Zeller, I | 1 |
| Asmis, R; Ullevig, SL; Zamora, D; Zhao, Q | 1 |
| Shan, JZ; Sun, M; Ying, HZ; Zhang, GP | 1 |
| Liu, J | 1 |
1 review(s) available for ursolic acid and Hyperlipemia
| Article | Year |
|---|---|
Pharmacology of oleanolic acid and ursolic acid.
Topics: Antineoplastic Agents, Phytogenic; Humans; Hyperlipidemias; Inflammation; Liver; Oleanolic Acid; Triterpenes; Ursolic Acid | 1995 |
5 other study(ies) available for ursolic acid and Hyperlipemia
| Article | Year |
|---|---|
Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit.
Topics: Animals; Aorta; Apolipoprotein A-I; Artemisinins; Artesunate; Cholesterol; Drug Therapy, Combination; Fatty Liver; Hyperlipidemias; Hypolipidemic Agents; Kruppel-Like Transcription Factors; Liver; Male; PPAR alpha; Rabbits; Receptors, LDL; Sterol Regulatory Element Binding Protein 1; Triglycerides; Triterpenes; Ursolic Acid; Vascular Cell Adhesion Molecule-1 | 2013 |
The hypolipidemic effect of artesunate and ursolic acid in rats.
Topics: Animals; Artemisinins; Artesunate; Atorvastatin; Cholesterol; Disease Models, Animal; Heptanoic Acids; Hyperlipidemias; Hypolipidemic Agents; Pyrroles; Rats; Triglycerides; Triterpenes; Ursolic Acid | 2015 |
Ursolic acid causes DNA-damage, p53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo.
Topics: Animals; Apolipoproteins E; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-X Protein; Caspases; Cell Proliferation; Cells, Cultured; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Down-Regulation; Human Umbilical Vein Endothelial Cells; Humans; Hyperlipidemias; Interleukin-5; Male; Mice; Mice, Knockout; Mitochondria; Plaque, Atherosclerotic; RNA Interference; Time Factors; Transfection; Triterpenes; Tumor Suppressor Protein p53; Ursolic Acid | 2011 |
Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.
Topics: Animals; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cell Line; Chemokine CCL2; Chemotaxis, Leukocyte; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Humans; Hyperlipidemias; Kidney; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Oxidative Stress; Receptors, CCR2; Receptors, LDL; Resveratrol; Stilbenes; Time Factors; Triterpenes; Ursolic Acid | 2011 |
[Experimental study on treating hyperlipidemic fatty liver with Taizhi'an capsule].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Capsules; Cholesterol; Drugs, Chinese Herbal; Fatty Liver; Hyperlipidemias; Ligustrum; Liver; Male; Malondialdehyde; Phytotherapy; Plant Leaves; Plants, Medicinal; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Triglycerides; Triterpenes; Ursolic Acid | 2007 |